awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50116255-B7C7DF0D-503A-433E-ABCA-9B88D182B3E5
Q50116255-B7C7DF0D-503A-433E-ABCA-9B88D182B3E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50116255-B7C7DF0D-503A-433E-ABCA-9B88D182B3E5
Talimogene Laherparepvec: First in Class Oncolytic Virotherapy.
P2860
Q50116255-B7C7DF0D-503A-433E-ABCA-9B88D182B3E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50116255-B7C7DF0D-503A-433E-ABCA-9B88D182B3E5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b04ba680bd1fa30c74982cddf16478f7a578bdbd
P2860
Differing patterns of circulating regulatory T cells and myeloid-derived suppressor cells in metastatic melanoma patients receiving anti-CTLA4 antibody and interferon-α or TLR-9 agonist and GM-CSF with peptide vaccination.